News | January 06, 2026
Abbott unveils Libre Assist to help meal management in diabetics
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
The company said it received notice on January 1 from the FDA’s Center for Veterinary Medicine that the funding will support its ongoing effectiveness study of Canalevia-CA1
The FDA acknowledged that Corcept’s pivotal GRACE trial met its primary endpoint and that data from the GRADIENT trial offered confirmatory evidence
Our scientists found that toxicological data for most PFAS are incomplete or unavailable, leaving significant uncertainty about consumer safety
India’s traditional medicine systems have also earned formal recognition in key bilateral trade agreements
He noted the enduring relevance of Siddha medicine as “a comprehensive, preventive and sustainable healthcare system in the contemporary world
The approval is supported by data from three pivotal clinical trials
Before this appointment, he served as the Secretary in the Department of Land Resources, Ministry of Rural Development
The Phase II study will assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of 9MW3811 in patients with pathological scarring
Subscribe To Our Newsletter & Stay Updated
